Español, A. J., Salem, A. R., Di Bari, M., Cristofaro, I., Sanchez, Y., Tata, A. M., & Sales, M. E. (2020). The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype. Web
Citación estilo ChicagoEspañol, Alejandro Javier, Agustina Reina Salem, María Di Bari, Ilaria Cristofaro, Yamila Sanchez, Ada Maria Tata, and María Elena Sales. The Metronomic Combination of Paclitaxel With Cholinergic Agonists Inhibits Triple Negative Breast Tumor Progression. Participation of M2 Receptor Subtype. 2020.
Cita MLAEspañol, Alejandro Javier, et al. The Metronomic Combination of Paclitaxel With Cholinergic Agonists Inhibits Triple Negative Breast Tumor Progression. Participation of M2 Receptor Subtype. 2020.